Monte Rosa Therapeutics, Inc.GLUENASDAQ
LOADING
|||
Switch Symbol:
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$2.20
Net Income/Share$0.25
Operating CF/Share$1.81
Free CF/Share$1.76
Cash/Share$4.75
Book Value/Share$2.98
Tangible Book/Share$2.98
Equity/Share$2.98
Interest Debt/Share$0.49
CapEx/Share$0.05
Dividend/Share$0.00
Valuation
Market Cap$1.35B
Enterprise Value$1.19B
P/E Ratio81.74P/S Ratio7.45P/OCF Ratio11.48
P/FCF Ratio9.33
P/B Ratio6.96P/TB Ratio6.96
EV/Sales6.53EV/EBITDA60.60
Graham Valuation
Graham Number$4.13
Graham Net-Net$2.20
Profitability
Earnings Yield1.22%FCF Yield10.72%ROE8.28%ROIC2.02%Return on Tangible Assets4.56%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF2.76%
CapEx/Revenue2.27%
CapEx/Depreciation0.46
SBC/Revenue10.48%
SG&A/Revenue14.09%
R&D/Revenue75.08%
Liquidity & Solvency
Debt/Equity0.16Debt/Assets0.09Debt/Market Cap0.03
Net Debt/EBITDA-8.60
Current Ratio6.54Interest Coverage0.00xIncome Quality7.12Efficiency
Days Sales Outstanding10 days
Days Payables Outstanding2528 days
Days Inventory0 days
Receivables Turnover36.56x
Payables Turnover0.14x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$245.84M
Working Capital$340.37M
Invested Capital$393.04M
Intangibles/Assets0.00%